EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Inhibition of LINC00707 / miR ‐223‐3p/ FKBP5 axis has a protective effect on diabetic kidney disease

Hongzhen Ye, Yiting Chen, Hong Xia, Lingbo Lv iD, Lijun Gao

Journal of Diabetes Investigation · 2025

DOI: 10.1111/jdi.70025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Investigation, 2025. Verfasst von Hongzhen Ye und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China. Hauptthemen laut MEDLINE: MicroRNAs, Diabetic Nephropathies, RNA, Long Noncoding. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: "LncRNA PVT1 acts as ceRNA to promote renal tubules in diabetic nephropathy Study on the mechanism of fibrosis and the intervention effect of Qigui drug pair"….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Research indicates that LINC00707 is abnormally expressed in patients suffering from diabetic kidney disease (DKD). Nevertheless, the precise role of LINC00707 in the context of DKD remains enigmatic and warrants further investigation.

Methods

Initially, RT‐qPCR was employed to assess the expression levels of LINC00707 in patients with DKD. Subsequently, we cultured glomerular podocytes under high‐glucose conditions. The effects of LINC00707 on cell proliferation, apoptosis, podocyte functionality (Podocin, Nephrin, and CD2AP), oxidative stress (MDA and SOD), and inflammatory responses (IL‐1β, IL‐6, and TNF‐α) were evaluated using CCK‐8, flow cytometry, RT‐qPCR, and ELISA assays. Finally, we co‐regulated LINC00707 alongside its downstream targets to elucidate the molecular mechanisms by which LINC00707 influences podocyte injury.

Results

LINC00707 is abnormally upregulated in DKD patients. Furthermore, a notable inverse correlation has been observed between LINC00707 levels and renal function in these patients. Upon downregulating LINC00707, we observed an increase in cellular proliferative activity, alongside elevated levels of Podocin, Nephrin, and CD2AP. Concurrently, the reduction of LINC00707 was associated with decreased levels of MDA, as well as proinflammatory cytokines. Significantly, the inhibition of miR‐223‐3p was found to reverse these observed effects. Further investigation revealed that miR‐223‐3p directly targets FK506‐binding protein 5 (FKBP5).

Conclusions

Inhibition of LINC00707 may reduce podocyte damage during hyperglycemia by targeting miR‐223‐3p/FKBP5.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsDiabetic NephropathiesRNA, Long NoncodingHumansPodocytesMaleCell ProliferationApoptosisFemaleOxidative StressCells, CulturedMiddle Aged

Stichwörter der Autor:innen

Diabetic kidney diseaseLINC00707/miR‐223‐3p/FKBP5 aixsPodocyte injury

Substanzen

MicroRNAsRNA, Long NoncodingMIR223, human

Autor:innen und Institutionen

  • Department of Laboratory Medicine, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China.
  • Department of Endocrinology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
  • Department of Nephrology, Shanghai Putuo District People's Hospital, Shanghai, China.
  • Department of Endocrinology, Shenzhen Diabetes Center, Shenzhen Second People's Hospital, Shenzhen Clinical Medical Research Center for Metabolic Diseases, Shenzhen, Guangdong, China.
  • Department of Geratology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.

ORCID-Profile: Lingbo Lv

Förderung

  • "LncRNA PVT1 acts as ceRNA to promote renal tubules in diabetic nephropathy Study on the mechanism of fibrosis and the intervention effect of Qigui drug pair"…

Zitieren

APA

Ye, H., Chen, Y., Xia, H., Lv, L., & Gao, L. (2025). Inhibition of LINC00707 / miR ‐223‐3p/ FKBP5 axis has a protective effect on diabetic kidney disease. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.70025

Vancouver

Ye H, Chen Y, Xia H, Lv L, Gao L. Inhibition of LINC00707 / miR ‐223‐3p/ FKBP5 axis has a protective effect on diabetic kidney disease. Journal of Diabetes Investigation. 2025. doi:10.1111/jdi.70025

BibTeX
@article{Ye2025,
  author = {Ye, Hongzhen and Chen, Yiting and Xia, Hong and Lv, Lingbo and Gao, Lijun},
  title = {Inhibition of LINC00707 / miR ‐223‐3p/ FKBP5 axis has a protective effect on diabetic kidney disease},
  journal = {Journal of Diabetes Investigation},
  year = {2025},
  doi = {10.1111/jdi.70025}
}
Kostenlos starten →